Skip to main content
Top
Published in: Supportive Care in Cancer 9/2010

Open Access 01-09-2010 | Original Article

Differential palliative care issues in patients with primary and secondary brain tumours

Authors: Christoph Ostgathe, Jan Gaertner, Maren Kotterba, Sebastian Klein, Gabriele Lindena, Friedemann Nauck, Lukas Radbruch, Raymond Voltz, For the Hospice and Palliative Care Evaluation (HOPE) Working Group in Germany

Published in: Supportive Care in Cancer | Issue 9/2010

Login to get access

Abstract

Introduction

Cancer may affect the central nervous system either by primary or secondary brain tumours (PBT/SBT). Specific needs of these patients and special requirements of services caring for them have not been adequately addressed so far.

Methods

Since 1999, an annual, 3-month census is being conducted in different palliative care settings throughout Germany. Pooled data from the years 2002–2005 were analysed to test for differences between patients with PBT, SBT and other palliative care patients (OP). Symptom frequencies, ECOG status and nursing needs were tested for differences (χ²). Free text entries for reasons for admission were recorded, categorised and analysed descriptively.

Results

A total of 5,684 patients were documented (PBT n = 153, 2.7%; SBT n = 661, 11.9%; OP n = 4,872, 85.4%). For patients with PBT, poor functional status and high need for nursing support was reported more frequently than for patients with SBT and OP. For patients with PBT/SBT physical symptoms (pain, nausea, vomiting, constipation and loss of appetite) were documented less frequently and in lower intensity than for OP. However, nursing, psychological, and social problems/symptoms were documented significantly more often and showed higher intensity, particularly the patients'’ need for support with the activities of daily living, disorientation/confusion of the patients and overburdening of the family. For 67% of all patients, a reason for admission was documented in free text. Main reasons were symptom control (OP>SBT>PBT), social issues (PBT>SBT>OP), functional deficits (PBT>SBT>OP) and cognitive impairment (PBT/SBT>OP). Distinct neurological deficits and problems were documented more often as secondary ICD-diagnoses than as a leading reason for admission.

Conclusion

The specific palliative care problems and the rationales leading to health care utilisation point to the need for an appropriate interdisciplinary and multi-professional provision of care for patients with brain malignancies, with a particular view on the needs of the families and an early integration of social and psychological support.
Footnotes
1
Due to the fact that data analysis, feedback to the institutions and discussion about modification of the instrument lasted 15 months on average, no census was performed in 2003. Since 2005, the census has been repeated annually, as the infrastructure is now optimised and the instrument can be used as a standard documentation tool.
 
2
According to the German long-term care legislation patients have to apply for a nursing level in order to receive financial aids. The grouping to a certain level implies a dedicated need for nursing support (higher level = higher need for nursing support (Table 3)) and aligns for a certain financial grant.
 
3
In Germany, palliative care units are medical units, integrated into hospitals and have an average stay of 9 days. Hospices focus on nursing needs, are freestanding, generally patients remain there until they die. Funding for services also differs.
 
Literature
1.
go back to reference Taillibert S, Delattre JY (2005) Palliative care in patients with brain metastases. Curr Opin Oncol 17:588–592CrossRefPubMed Taillibert S, Delattre JY (2005) Palliative care in patients with brain metastases. Curr Opin Oncol 17:588–592CrossRefPubMed
2.
go back to reference Pease NJ, Edwards A, Moss LJ (2005) Effectiveness of whole brain radiotherapy in the treatment of brain metastases: a systematic review. Palliat Med 19:288–299CrossRefPubMed Pease NJ, Edwards A, Moss LJ (2005) Effectiveness of whole brain radiotherapy in the treatment of brain metastases: a systematic review. Palliat Med 19:288–299CrossRefPubMed
3.
4.
go back to reference Ohgaki H, Dessen P, Jourde B et al (2004) Genetic pathways to glioblastoma: a population-based study. Cancer Res 64:6892–6899CrossRefPubMed Ohgaki H, Dessen P, Jourde B et al (2004) Genetic pathways to glioblastoma: a population-based study. Cancer Res 64:6892–6899CrossRefPubMed
5.
go back to reference Smith JS, Jenkins RB (2000) Genetic alterations in adult diffuse glioma: occurrence, significance, and prognostic implications. Front Biosci 5:D213–231CrossRefPubMed Smith JS, Jenkins RB (2000) Genetic alterations in adult diffuse glioma: occurrence, significance, and prognostic implications. Front Biosci 5:D213–231CrossRefPubMed
6.
go back to reference Langer CJ, Mehta MP (2005) Current management of brain metastases, with a focus on systemic options. J Clin Oncol 23:6207–6219CrossRefPubMed Langer CJ, Mehta MP (2005) Current management of brain metastases, with a focus on systemic options. J Clin Oncol 23:6207–6219CrossRefPubMed
7.
go back to reference WHO (2002) National cancer control programmes - policies and managerial guidelines. WHO, Geneva WHO (2002) National cancer control programmes - policies and managerial guidelines. WHO, Geneva
8.
go back to reference Bausewein C, Hau P, Borasio GD et al (2003) How do patients with primary brain tumours die? Palliat Med 17:558–559CrossRefPubMed Bausewein C, Hau P, Borasio GD et al (2003) How do patients with primary brain tumours die? Palliat Med 17:558–559CrossRefPubMed
10.
go back to reference Radbruch L, Nauck F, Ostgathe C et al (2003) What are the problems in palliative care? Results from a representative survey. Support Care Cancer 11:442–451CrossRefPubMed Radbruch L, Nauck F, Ostgathe C et al (2003) What are the problems in palliative care? Results from a representative survey. Support Care Cancer 11:442–451CrossRefPubMed
11.
go back to reference Radbruch L, Ostgathe C, Elsner F et al (2004) What is the profile of palliative care in Germany. Results of a representative survey. Schmerz 18:179–188PubMed Radbruch L, Ostgathe C, Elsner F et al (2004) What is the profile of palliative care in Germany. Results of a representative survey. Schmerz 18:179–188PubMed
12.
go back to reference Radbruch L, Nauck F, Fuchs M et al (2002) What is palliative care in Germany? Results from a representative survey. J Pain Symptom Manage 23:470–482CrossRef Radbruch L, Nauck F, Fuchs M et al (2002) What is palliative care in Germany? Results from a representative survey. J Pain Symptom Manage 23:470–482CrossRef
13.
go back to reference Radbruch L, Nauck F, Sabatowski R (2002) Germany: Cancer pain and palliative care—current situation. J Pain Symptom Manage 24:183–187CrossRefPubMed Radbruch L, Nauck F, Sabatowski R (2002) Germany: Cancer pain and palliative care—current situation. J Pain Symptom Manage 24:183–187CrossRefPubMed
14.
go back to reference Nauck F, Ostgathe C, Klaschik E et al (2004) Drugs in palliative care: results from a representative survey in Germany. Palliat Med 18:100–107CrossRefPubMed Nauck F, Ostgathe C, Klaschik E et al (2004) Drugs in palliative care: results from a representative survey in Germany. Palliat Med 18:100–107CrossRefPubMed
15.
go back to reference Oken MM, Creech RH, Tormey DC et al (1982) Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 5:649–655CrossRefPubMed Oken MM, Creech RH, Tormey DC et al (1982) Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 5:649–655CrossRefPubMed
16.
go back to reference Busse R, Riesberg A (2004) Health care systems in transition: Germany. WHO Regional Office for Europe, on behalf of the European Observatory on Health Systems and Policies, Copenhagen Busse R, Riesberg A (2004) Health care systems in transition: Germany. WHO Regional Office for Europe, on behalf of the European Observatory on Health Systems and Policies, Copenhagen
17.
go back to reference Schindler T (2006) Palliative care in Germany. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 49:1077–1086CrossRefPubMed Schindler T (2006) Palliative care in Germany. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 49:1077–1086CrossRefPubMed
18.
go back to reference Bausewein C, Borasio GD, Voltz R (2005) Brain tumours. In: Doyle D et al (eds) Oxford textbook of palliative medicine, 3rd edn. Oxford University Press, Oxford, pp 727–730 Bausewein C, Borasio GD, Voltz R (2005) Brain tumours. In: Doyle D et al (eds) Oxford textbook of palliative medicine, 3rd edn. Oxford University Press, Oxford, pp 727–730
19.
go back to reference Ostgathe C, Voltz R (2008) Brain metastases. In: Walsh TD (ed) Palliative medicine, 1st edn. Mosby Inc. Philadelphia, pp 1240–1244 Ostgathe C, Voltz R (2008) Brain metastases. In: Walsh TD (ed) Palliative medicine, 1st edn. Mosby Inc. Philadelphia, pp 1240–1244
20.
go back to reference Oberndorfer S, Lindeck-Pozza E, Lahrmann H et al (2008) The end-of-life hospital setting in patients with glioblastoma. J Palliat Med 11:26–30CrossRefPubMed Oberndorfer S, Lindeck-Pozza E, Lahrmann H et al (2008) The end-of-life hospital setting in patients with glioblastoma. J Palliat Med 11:26–30CrossRefPubMed
21.
go back to reference Namba M, Morita T, Imura C et al (2007) Terminal delirium: families' experience. Palliat Med 21:587–594CrossRefPubMed Namba M, Morita T, Imura C et al (2007) Terminal delirium: families' experience. Palliat Med 21:587–594CrossRefPubMed
22.
go back to reference Morita T, Akechi T, Ikenaga M et al (2007) Terminal delirium: recommendations from bereaved families' experiences. J Pain Symptom Manage 34(6):579–589CrossRefPubMed Morita T, Akechi T, Ikenaga M et al (2007) Terminal delirium: recommendations from bereaved families' experiences. J Pain Symptom Manage 34(6):579–589CrossRefPubMed
23.
go back to reference Faithfull S, Cook K, Lucas C (2005) Palliative care of patients with a primary malignant brain tumour: case review of service use and support provided. Palliat Med 19:545–550CrossRefPubMed Faithfull S, Cook K, Lucas C (2005) Palliative care of patients with a primary malignant brain tumour: case review of service use and support provided. Palliat Med 19:545–550CrossRefPubMed
24.
go back to reference Davies E, Clarke C, Hopkins A (1996) Malignant cerebral glioma–II: perspectives of patients and relatives on the value of radiotherapy. BMJ 313:1512–1516PubMed Davies E, Clarke C, Hopkins A (1996) Malignant cerebral glioma–II: perspectives of patients and relatives on the value of radiotherapy. BMJ 313:1512–1516PubMed
Metadata
Title
Differential palliative care issues in patients with primary and secondary brain tumours
Authors
Christoph Ostgathe
Jan Gaertner
Maren Kotterba
Sebastian Klein
Gabriele Lindena
Friedemann Nauck
Lukas Radbruch
Raymond Voltz
For the Hospice and Palliative Care Evaluation (HOPE) Working Group in Germany
Publication date
01-09-2010
Publisher
Springer-Verlag
Published in
Supportive Care in Cancer / Issue 9/2010
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-009-0735-y

Other articles of this Issue 9/2010

Supportive Care in Cancer 9/2010 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine